Skip to main content
. 2022 Mar 4;6(5):1547–1558. doi: 10.1182/bloodadvances.2021005941

Figure 1.

Figure 1.

Clinical responses after ASCT and mRNA-electroporated LC vaccines. (A) Depth of response pre-ASCT and at days +90 (d90) and +365 (d365) after ASCT. Relapse is also indicated. PFS and OS for patients in the control arm (B) and the vaccine arm (C). D, deceased; R, relapse.